Antibody (1)
Launched (1)
Rabbit (1)
- (1)
Unconjugated (1)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|---|
- | Recombinant Monoclonal Anti-CDH17 Antibody, Rabbit (12C3) |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| TEV-56192 | TEV-56192 | Phase 1 Clinical | Teva Pharmaceutical Industries Ltd | Nervous System Diseases | Details |
| OA-235i | OA-235i | Phase 1 Clinical | Oasis Pharmaceuticals LLC | Metabolic Dysfunction-Associated Steatotic Liver Disease | Details |
| MEDI-0618 | MEDI-0618 | Phase 1 Clinical | Astrazeneca Plc | Chronic Pain | Details |

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)
メールアドレス
order.jp@acrobiosystems.com
アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8



